Free Trial

Gyre Therapeutics (GYRE) SEC Filings & 10K Form

Gyre Therapeutics logo
$9.26 -0.08 (-0.86%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$9.60 +0.35 (+3.73%)
As of 04:34 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Gyre Therapeutics SEC Filings

DateFilerForm TypeView
04/28/2025
6:05 AM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
12:44 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form ARS
04/21/2025
4:23 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form DEF 14A
04/21/2025
4:23 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form DEFA14A
03/20/2025
3:01 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/17/2025
3:15 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
7:00 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:02 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
5:01 AM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
7:45 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:01 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:01 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:01 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:01 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
3:01 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:01 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:01 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:05 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Zhang Ping (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:05 AM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
3:06 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:01 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:01 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2024
11:15 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form EFFECT
11/13/2024
3:05 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
7:45 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
7:31 AM
GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Ma Songjiang (Filed by)
Form SC 13D
09/06/2024
7:15 AM
GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Luo Ying (Filed by)
Form SC 13D
08/16/2024
8:13 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:53 PM
Chen Ruoyu (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:56 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Luo Ying (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:58 PM
Eastling Thomas Wilson (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
8:01 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
8:05 PM
Carmichael Gordon (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
8:07 PM
Epstein David M. (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
8:10 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Parry Renate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:50 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ying Han (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
8:04 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:23 PM
Epstein David M. (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
3:31 PM
GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
3:27 PM
GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
4:19 PM
GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Elon’s Terrifying Warning Forces Trump To Take Action (Ad)

Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...

07/12/2024
3:41 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form RW
07/12/2024
3:42 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form RW
07/05/2024
3:45 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
3:45 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
12:18 PM
GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
4:56 PM
GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
5:00 PM
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
USMAN NASSIM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
4:19 PM
GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:30 PM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
7:00 AM
GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:GYRE) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners